______________________________________________________REFERÊNCIAS BIBLIOGRÁFICAS
88
Kuo, K. W., Chen, Y. C. & Chang, C. C. (1995) cDNA sequence analysis and
expression of alpha-bungarotoxin from Taiwan banded krait (Bungarus multicinctus),
Biochem Biophys Res Commun. 216, 1088-94.
Lin, M. K., Farewell, V., Vadas, P., Bookman, A. A., Keystone, E. C. & Pruzanski, W.
(1996) Secretory phospholipase A2 as an index of disease activity in rheumatoid
arthritis. Prospective double blind study of 212 patients, J Rheumatol. 23, 1162-6.
Liu, S. Y., Yoshizumi, K., Oda, N., Ohno, M., Tokunaga, F., Iwanaga, S. & Kihara, H.
(1990) Purification and amino acid sequence of basic protein II, a lysine-49-
phospholipase A2 with low activity, from Trimeresurus flavoviridis venom, J Biochem
(Tokyo). 107, 400-8.
Lomonte, B., Lundgren, J., Johansson, B. & Bagge, U. (1994) The dynamics of local
tissue damage induced by Bothrops asper snake venom and myotoxin II on the
mouse cremaster muscle: an intravital and electron microscopic study, Toxicon. 32,
41-55.
Maraganore, J. M. & Heinrikson, R. L. (1986) The lysine-49 phospholipase A2 from
the venom of Agkistrodon piscivorus piscivorus. Relation of structure and function to
other phospholipases A2, J Biol Chem. 261, 4797-804.
Marti-Renom, M. A., Stuart, A. C., Fiser, A., Sanchez, R., Melo, F. & Sali, A. (2000)
Comparative protein structure modeling of genes and genomes, Annu Rev Biophys
Biomol Struct. 29, 291-325.
Mounier, C. M., Bon, C. & Kini, R. M. (2001) Anticoagulant venom and mammalian
secreted phospholipases A(2): protein- versus phospholipid-dependent mechanism of
action, Haemostasis. 31, 279-87.
Murakami, M., Kudo, I., Suwa, Y. & Inoue, K. (1992) Release of 14-kDa group-II
phospholipase A2 from activated mast cells and its possible involvement in the
regulation of the degranulation process, Eur J Biochem. 209, 257-65.
Nakae, H., Endo, S., Inada, K., Yamashita, H., Yamada, Y., Takakuwa, T., Kasai, T.,
Ogawa, M. & Uchida, K. (1995) Plasma concentrations of type II phospholipase A2,
cytokines and eicosanoids in patients with burns. , Burns 21, 422–426.